MedPath

Validation of the SIGAM/VF Mobility Grade

Completed
Conditions
Amputation
Interventions
Other: SIGAM Questionnaire
Registration Number
NCT02859740
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Brief Summary

The objective of this study is to demonstrate the validity, the reproducibility and the coherence of the French version of the Special Interest Group in Amputee medicine (SIGAM) mobility scale questionnaire in adults with lower-limb amputations.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Aged 18 to 80 years

  • Patients who have been informed about the research

  • Patients with national health insurance cover

  • Patients who accepted to take part in the study

  • Able to understand simple instructions

  • With transtibial, femoral, or bilateral amputation of the lower limb

  • Whatever the etiology

  • Patients able to do the 2-minute walk test

  • Group 1:

    • Patients in the stabilized phase of the definitive prosthesis, with no modification of the prosthesis in the previous 3 months and at more than 6 months after the amputation.
  • Group 2:

    • Patients in the initial phase of management (temporary prosthesis, rehabilitation) post trans-tibial unilateral amputation
Exclusion Criteria
  • Patient without national health insurance cover.
  • Patients under guardianship.
  • Pregnant or breast-feeding women.
  • Alteration of executive functions making understanding of and compliance with the research protocol impossible (Mini Mental State Examination<20)
  • Associated chronic motor deficiency, of neurological origin (examples: sequelae of stroke, balance and coordination disorders), or of osteo-articular origin (examples: knee or hip osteoarthritis), or due to secondary functional repercussions making it impossible to walk with a prosthesis.
  • Severe medical disorder that significantly impairs functional capacities (severe heart failure, respiratory failure, non-stabilized metabolic disorders such as progressive kidney failure) that is life-threatening in the short or medium term (Progressive neoplastic disease, non-stabilized systemic disease).
  • Complications at the stump other than microcirculation that could affect the application of a contact socket/sleeve: haematoma, Cysts, effusion, calcifications of soft tissues, bone spurs, infection (skin, abscess), neuroma, deterioration of the knee of the amputated limb, specifically painful Farabeuf angle (compression between bone and skin), venous thrombosis, abnormal stump shape making it impossible to use a socket (flexion of the knee, "pear-shaped", "deep-scar" stump...)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Temporary prosthesisSIGAM Questionnaire-
permanent prosthesisSIGAM Questionnaire-
Primary Outcome Measures
NameTimeMethod
Answers to the SIGAM mobility scale questionnaireChange from baseline at Week 2 and Week 3
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Dijon Bourgogne

🇫🇷

Dijon, France

© Copyright 2025. All Rights Reserved by MedPath